NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the development and commercialization of small molecule drugs and recombinant proteins.

Recs

3
Player Avatar cashsage (30.01) Submitted: 12/17/2009 12:56:54 PM : Underperform Start Price: $3.08 NPSP Score: -334.64

NPSP has an illiquid balance sheet and a too high valuation compared to its sales potential. It is also loss making at least until 2011.

Report this Post Reply

Featured Broker Partners


Advertisement